Common features of immune-metabolic and inflammatory diseases such as metabolic syndrome, diabetes, obesity and cardiovascular diseases are an altered gut microbiota composition and a systemic pro-inflammatory state. We demonstrate that active immunization against the outer membrane protein of bacteria present in the gut enhances local and systemic immune control via apoE-mediated immune-modulation. Reduction of western-diet-associated inflammation was obtained for more than eighteen weeks after immunization. Immunized mice had reduced serum cytokine levels, reduced insulin and fasting glucose concentrations; and gene expression in both liver and visceral adipose tissue confirmed a reduced inflammatory steady-state after immunization. Moreover, both gut and atherosclerotic plaques of immunized mice showed reduced inflammatory cells and an increased M2 macrophage fraction. These results suggest that adaptive responses directed against microbes present in our microbiota have systemic beneficial consequences and demonstrate the key role of apoE in this mechanism that could be exploited to treat immune-metabolic diseases.
The gut microbiota (GM) has coevolved with humans and, as a multicellular organ, communicates with the host and modulates its physiology1. Recently, our group and others demonstrated that the B cells present in both coronary and carotid plaques of patients with cardiovascular diseases locally produce antibodies able to react against GM antigens and to cross-react with self-antigens. We demonstrated that IgG1 immunoglobulins are secreted in human coronary atherosclerotic lesions and recognize the outer membrane proteins of Enterobacteriaceae, such as Klebsiella and Proteus strains, bacteria present in the GM of healthy subjects. Interestingly, this family of bacteria was recently shown to be also a major component of human atherosclerotic lesions-associated microbiome2.
The nasal vaccination of hyperlipidemic apolipoprotein E (apoE)-deficient mice with the outer membrane protein of Porphyromonas gingivalis (P. gingivalis), a gram-negative microorganism that resides in the oral cavity, reduced atherosclerotic plaques and lowered circulating levels of inflammatory cytokines upon bacterial challenge3. The underlying mechanisms are still not fully elucidated and immunization with bacterial antigens produced significant effects only if atherosclerosis was accelerated through intraperitoneal bacterial inoculation. Moreover, those results were obtained in apoE-deficient mice, a pre-clinical model of atherosclerotic disease and not on wild type animals.
Several genetic risk markers for immune-metabolic diseases such as atherosclerosis, including apoE, are associated with pathogen recognition or inflammatory pathways. In fact apoE, the major component of Very Low Density Lipoproteins (VLDL) is known to modulate plasma lipoprotein clearance, to affect immune activation on antigen presenting cells (i.e. suppression of pro-inflammatory signaling in macrophages and down-regulation of T helper 1-related immune responses)4,5,6 and to be a recognized determinant of cardiovascular disease susceptibility7.
Herein, in order to evaluate the effect of systemic immunity against the outer membrane proteins of Enterobacteriaceae on atherosclerosis progression and on the proinflammatory status associated with hyperlipidic diet (WD), we immunized C57BL/6 wild type and ApoE−/− mice fed with WD against the outer membrane protein K36 (ompK36) of Klebsiella pneumoniae.
We demonstrate that immunized C57BL/6 wild type mice had reduced serum cytokine levels, reduced insulin and fasting glucose concentrations and both gut and atherosclerotic plaques of immunized mice showed reduced inflammatory cells and an increased fraction of alternatively-activated macrophages. We also demonstrate that the reduced systemic pro-inflammatory state associated with immunization is due to the enhancement of ApoE-mediated immune regulation. Our data clarify that the interplay between genetic background, GM and acquired immunity: i) is biologically relevant; ii) affects hormone levels, cytokine milieu, pro/anti-inflammatory balance in peripheral organs and atherosclerotic plaque composition also for a long time after immunization; iii) could be therapeutically exploited to protect from WD-associated inflammation and metabolic syndrome.
Immunization with ompK36 affects apoE, cytokine and hormone production in serum and gene expression in the liver and visceral adipose tissues
In mice immunized with ompK36 antigen, the titer of circulating antigen-specific IgG antibodies at euthanization was higher than 7 × 104, while no significant (<10) specific reactivity was present in non-immunized control mice (Fig. S1c). Differences in Total Cholesterol (TC), LDL-cholesterol (LDL-c) and Triglycerides (TG) concentrations were not observed between immunized or control animals (Fig. S2a). No significant changes in weight gain or in food consumption were observed between immunized and mock-immunized groups in C57BL/6 or ApoE−/− mice (Fig. S2b,c).
OmpK36 immunization increased serum levels of apoE protein in C57BL/6 animals fed with WD (Fig. 1A). Interestingly, no changes in the expression level of apoE mRNA could be demonstrated in the liver of ompK36-immunized C57BL/6 mice, even if an increase in plasma levels of apoE protein was confirmed, suggesting that modification of plasmatic apoE was not due to hepatic upregulation.
OmpK36 immunization in C57BL/6 mice resulted in a significant reduction of several circulating pro-inflammatory cytokines and chemokines such as IL-1α, IL-1β, IL-18, IFN-γ, IL-6, CXCL2 (Fig. 1C and Fig. S3), IL-5, IL-15 (Fig. S3).
In C57BL/6 mice, immunization with ompK36 was associated with the following changes in gene expression: in the liver, PPARγ (1,46, p = 0.05) was increased and IL-6 gene expression (−2,02, p = 0.04) (Fig. 2A) was reduced; while in the abdominal adipose tissue, (Fig. 2C) IL-6 (−2,15; p = 0.05) was decreased and IFN-α2 (1,72, p = 0.04) was increased compared to control mice. No significant differences in the gene expression profiles of the spleen, PBMCs, or striated muscles were observed as a result of immunization.
Interestingly, ompK36 immunization decreased fasting glucose and the plasma insulin, level in C57BL/6 mice compared to mock-immunized mice (Fig. 1B,E).
In ompK36-immunized ApoE−/− mice, not only pro-inflammatory cytokines such as IL-1β, IL-18, IFN-γ, IL-6, (Fig. 1C) and TNF-α, IL-1α and LIF (Figs S3a and S4c) but also anti-inflammatory cytokines such as IL-4, IL-10 (Fig. 1D) and IL-13 (Fig. S3d) were increased in the peripheral blood, in comparison with mock-immunized mice. In ApoE−/− mice, no inflammatory genes were modified in the liver following ompK36 immunization and only Interferon Receptor Substrate-1 (IRS-1) expression was significantly reduced (−1,67) (Fig. 2B). Conversely, several significant changes were found in the visceral adipose tissue: anti-inflammatory genes such as IκBα (1,39), RORC (RORγ) (1,76; p = 0.056) were increased and pro-inflammatory cytokine genes such as IL-6 were decreased (−2,27) (Fig. 2D). In addition, JNK1 (MAPK8) (1,21), IL-1 receptor (IL1R) (1,52), Tyk2 (2,19), IFNαR1 (1,53) genes were increased in the adipose tissue of ompK36-immunized ApoE−/− mice with respect to mock-immunized ones (Fig. 2D), suggesting an immune-metabolic activation. As observed in WT mice, no significant differences in the gene expression profiles of the spleen, PBMCs, or striated muscles were observed as a result of immunization.
Interestingly, these changes were observed several months after the last burst of immunization, supporting the hypothesis of a long-lasting adaptation of the immune-metabolism.
Changes in microbiota composition are modulated by genetics and immunization
In agreement with previous literature8, in both strains of mice a high Firmicutes/Bacteroidetes ratio was observed (Fig. S5a). However, immunization with ompK36 significantly altered the composition of the GM only in ApoE−/− mice (Fig. 3A–C). ApoE−/− mice immunized with ompK36 exhibited a significant alteration in the proportions of some bacterial clades: Bacteroides spp. were decreased, whereas S24-7, Proteobacteria and Porphiromonadaceae were increased (Fig. S5b).
In both C57BL/6 and ApoE−/− mice, the presence of specific Operational Taxonomic Units (OTUs), i.e specific bacterial strains, was significantly correlated with animal traits including weight, serum biochemical and inflammatory parameters and hormone levels (Fig. 3D).
Gut and atherosclerotic plaques of immunized mice show reduced inflammatory cells and an increased M2 macrophage fraction
Atherosclerotic plaques of murine aortas were quantitatively analyzed by applying a novel ex vivo quantitative Magnetic Resonance Imaging (MRI) technique, specifically developed for this study. Plaques were successively analyzed by morphometry with transmitted light and fluorescence microscopy. In the aortic arches of ApoE−/− mice, major atherosclerotic plaques were localized in the proximity of the aortic sinus, but no significant differences in plaque distribution along the aortic arch were demonstrated between ompK36-immunized and mock-immunized mice (Fig. 4A–C). MRI evaluated the volume and the number of plaques on the aortic root (as by morphometry) and along the entire length of the aortic arch through a fine-tuned operator-independent assessment. By MRI, the total volume of the aortic plaques in ompK36-immunized mice (mean value = 1.1 mm3) showed a tendency to be lower than in mock-immunized mice however, statistical significance was not reached (Fig. 4E). Consistently, morphometry on Sirius red and Oil Red O-stained pseudo-serial sections of the aortic root did not reveal any significant difference among ApoE−/− mice groups neither in plaque area, calcification, collagen, nor in lipid content (Fig. 5A). However, in the absence of significant differences in the total cell density of the aortic plaques, the percentage and density of CD68+ cells was significantly lower in ompK36 immunized ApoE−/− mice with respect to mock-immunized mice. Along with the decrease in CD68+ cells, a significantly increased proportion of CD68+/Arginase I+ cells, suggestive of alternatively activated (M2) macrophages, was found in plaques of ompK36-immunized mice with respect to mock-immunized mice (Fig. 5B).
CD3+ and CD68+ cells were evaluated on sections of the small intestine (Fig. 6A,B). Quantitative analysis in C57BL/6 mice immunized with ompK36 demonstrated a lower density of CD3+ cells compared to mock-immunized mice (Fig. 6C). In ApoE−/− mice, no difference was detected in immunized mice. In all mice, the percentage of CD68+ cells was lower in ompK36-immunized mice compared to mock-immunized mice, independently of apoE presence or deficiency. This suggests that apoE function is needed to amplify the immune modulating effects of immunization. Moreover, all of the ompK36–immunized C57BL/6 mice showed enrichment in CD68+/CD206+ alternatively activated macrophages compared to mock-immunized mice; while ApoE−/− mice failed to show significant differences in the number of CD68+/CD206+ cells on gut sections (Fig. 6C).
We have demonstrated that adaptive responses following active immunization against Enterobacteriaceae, enhanced local and systemic immune-control by eliciting and maintaining a new equilibrium with bacteria present in the gut. In these settings, the presence/deficiency of apoE, fundamental for the proper activity of the machinery, has physiological consequences on the host’s metabolic and inflammatory status.
In fact, the enhanced circulating levels of apoE observed in immunized C57BL/6 animals could promote Toll-like Receptor (TLR) 3 and 4 inhibition, macrophage differentiation9, LPS hepatic clearance10 and can attenuate inflammatory responses by binding to LPS11. A direct physiological link between apoE immunomodulation and adaptive immune response against bacterial OMPs or its outcome was still unknown. ApoE, produced and released by many cell types (hepatocytes, smooth muscle cells, neuronal cells) represents up to 10% of proteins constitutively secreted by macrophages12 after contact with immune complexes and Fcγ receptor engagement13. In this study, we demonstrate that, when “guided” by the adaptive immune response, apoE plays a key role in tuning a local host immune response, acting on sites where frequent and elevated inflammatory reactivity could be detrimental. In conditions of low-grade chronic inflammation triggered by WD, previously described as metabolic endotoxemia or “metaflammation”, pro-inflammatory cytokines increase in the serum and influence the development of metabolic diseases, such as insulin resistance, metabolic syndrome, atherosclerosis and NAFLD/NASH14,15,16,17. Interestingly, IL-1β, IL-6, IFN-γ, CXCL2 (MIP-2), IL-18, IL-15, fasting glucose and insulin levels were significantly reduced in C57BL/6 mice upon immunization against ompK36, suggesting that eliciting a long lasting systemic immune response against antigens of GM microbes can confer significant protection on the murine WD-associated host dysmetabolism, similar to that observed in human metabolic diseases.
The key role of apoE in this protective mechanism was evident when immunization was performed on ApoE−/− animals. In ApoE−/− mice, gut immunomodulation was not as effective as in C57BL/6 wild type animals, since the composition of the GM and the circulating cytokines were highly susceptible to perturbations upon immunization. However, the expression of pro-inflammatory cytokines within visceral adipose tissue was decreased and a tendency to develop smaller atherosclerotic lesions was also present. These effects may be due to the decreased total number of macrophages and to the increased proportion of alternatively activated macrophages (M2), which have been related in humans to stable asymptomatic plaques18. Although the increase in circulating cytokines observed in ApoE−/− mice cannot be associated to a specific pattern, it resembled, with a reduced intensity, the “cytokine storm” observed in gram-negative sepsis or LPS-induced shock19. Fcγ receptor engagement, alone, triggers cytokine production by macrophages in response to LPS in vitro20. Therefore, immunization of C57BL/6 wild type mice with ompK36 allows simultaneous FcγR and TLR engagement and in vivo apoE release. This can explain the enhanced commitment of macrophages toward an anti-inflammatory phenotype, the lower number of CD3+ T lymphocytes and macrophages in the gut21,22,23,24, as well as the considerably reduced levels of circulating cytokines observed only in wild type mice.
Of note, in C57BL/6 mice, immunization decreased serum levels of the inflammasome-related IL-1β25,26,27. Interestingly, inflammasome-related inflammation has been suggested as risk factor for autoimmune and immuno-metabolic diseases including metabolic syndrome and and NAFLD28,29 and frequently associated to intestinal infections and reactions to dietary antigens potentially capable of altering normal intestinal function. Moreover both IL-6 and the expression of its receptor (gp130) were recently demonstrated to affect macrophage infiltration during atherosclerosis in ApoE−/− mice30 and the risk of myocardial infarction in humans31.
Importantly, the role of apoE immunomodulatory functions in the context of both adaptive and innate responses against other microbes or against self-antigens such as oxidized-LDL should also be taken into consideration. Interestingly, in fact, Binder’s group a few years ago showed that pneumococcal vaccination decreases atherosclerotic lesion formation through a molecular mimicry mechanism between Streptococcus pneumoniae and oxidized LDL32. It was later demonstrated that natural immunity against the cross-reactive phosphorylcholine epitope or against modified LDL was associated with protection from atherosclerosis33,34,35,36,37. In contrast, other groups suggested that adaptive immune responses contribute to the development of atherosclerosis by promoting inflammation and plaque growth38,39,40. However, the roles of both innate and adaptive immune responses were mostly investigated using the ApoE−/− mouse model of atherosclerosis and our results may help to clarify the apparently contrasting results observed. Future studies should in fact clarify to what extent apoE function affects innate or adaptive responses against oxidized-LDL or exogenous antigens in animals or in humans, since its systemic immunomodulatory functions may affect both circulating cytokine composition or local macrophage differentiation that at least in part, mediate both the oxidation of LDL and the inflammatory-cell composition of the plaques.
In our settings, apoE appeared also to be a key regulator in the homeostasis of gut immunity, whose pleiotropic functions strongly influenced the blood and intestinal microenvironment. Consistently, in C57BL/6 animals, systemic immunization did not affected GM composition, including the proportion of Enterobacteriaceae; whereas in ApoE−/− mice, immunization contributed to modify GM diversity and composition. In ApoE−/− mice, after immunization with ompK36 less Bacteroides but increased Proteobacteria, S24-7, Porphyromonadaceae and Enterobacteriaceae were found with patterns similar to those observed in inflammatory conditions as diabetes, metabolic syndrome and NAFLD41,42,. This suggests that both local and systemic responses against bacteria present in the gut are strongly influenced by apoE function and strongly shape the composition of GM. Alteration in GM composition and function has been associated with human disorders such as metabolic syndrome, diabetes, obesity14,43,44 and atherosclerosis, including its acute complications, i.e. stroke or myocardial infarction45,46,47. However, the environmental or genetic factors responsible also for affecting GM diversity and accounting for the multifactorial pathogenesis of these diseases require integrated “omics” approaches. In mice, a hyperlipidic diet per se was shown to modify GM composition, increase gut permeability and alter the systemic inflammatory profile17,48.
Enterobacteriaceae, present in the GM of healthy subjects, can cause opportunistic infections only in situations of altered immunity or gut barrier function. It cannot be excluded that immunization with antigens of other members of the GM has similar effects. However, it can be speculated that the different in vivo exposure to gut bacteria, the different ecological niches present in the gut, or the breadth of the immune response against bacteria with homologous or cross-antigenic OMPs may affect the biological consequences of immunization. Nasal immunization with the OMP of Porphyromonas gingivalis was previously shown to be protective against accelerated atherosclerosis induced by intraperitoneal inoculation of bacteria in ApoE−/− mice. In this paper we demonstrate the effect of immunization in wild type and in ApoE−/− animals after almost five months from last immunization and in the absence of bacterial challenge. P. gingivalis mainly colonize only the oral cavity, while Enterobacteriaceae, such as K. pneumoniae or P. mirabilis (the antibodies that we previously cloned from human plaques and those elicited in these animals, react against several cross-antigenic OMPs, including OmpK36, OmpK35 and OmpF from other Enterobacteria; data not shown), can adhere to the gut mucosa both in the small and in the large intestine, transiently translocating through the epithelial barrier, a process facilitated by WD, thus constantly in challenge with the gut immune system49,50. Moreover, gram-negative bacteria such as Enterobacteriaceae can release Outer Membrane Vesicles (OMVs) made up of the outer membrane components containing LPS, OMPs, other virulence factors and Pathogen Associated Molecular Patterns. OMVs can be detected in human tissues and can trigger local and systemic inflammatory responses51,52,53. Through the circulation, bacteria can reach visceral fat or atheromas2, directly promoting local inflammation or eliciting specific immune responses54,55 and indirectly influencing host metabolism and systemic inflammation56,57.
The lifestyle in developed countries has probably decreased the chances of building a proper immune equilibrium early in life with members of the GM, such as Enterobacteriaceae or with pathogens that can be frequently encountered during life in developing countries. Modified habits in Western lifestyles have led to an increasing number of inflammatory and autoimmune diseases, as suggested several decades ago by the supposed “Hygiene Hypothesis” that explains this fact by an increase on hygiene standards and lack of infectious stimuli during the early postnatal period58. Consequently, innate modulators of local and peripheral immune activation such as apoE cannot be physiologically exploited. It was also suggested that the composition of intestinal microbiota plays a key role in the development of inflammatory diseases by influencing host immune responses and the development of regulatory T cells59. Recently, Stepankova et al.46 have shown that ApoE−/− mice bred under germ-free conditions and fed with low cholesterol diet develop atherosclerotic lesions that do not develop in conventionally reared mice fed with the same diet. Thus suggesting that intestinal microbiota have a crucial protective effect against the formation of atherosclerotic plaques, that as we show in this paper may be, at least in part, mediated by the adaptive immune response against gut microbes.
In conclusion, Active immunization against Enterobacteriaceae can persistently restore the equilibrium between the host and the GM, by triggering apoE-mediated immune regulation and leading to a reduced systemic inflammatory steady state. However, in humans, ApoE exists in 3 common isoforms and numerous reports have established that only APOE4 allele is associated with an increased risk of premature atherosclerosis7. Similarly, its immunomodulatory properties were shown to be isoform-dependent4,5 independently of its role in lipoprotein metabolism6. Thus we cannot exclude that the observed mechanism could have different effects in humans bearing distinct ApoE alleles. However, future active or passive immunotherapeutic approaches for immune-metabolic diseases and to protect from atherosclerosis progression or degeneration, should be considered in humans by selectively targeting members of the GM.
Materials and Methods
Preparation of bacterial antigens
OmpK36 gene was amplified from Klebsiella pneumoniae lysate by using specific primers and cloned into a pET-28b expression vector (Novagen). Induction of protein expression was performed following manufacturer instructions (pET System Manual - Novagen), using a final IPTG concentration of 1 mM. Immobilized Metal Affinity Chromatography (IMAC) purification of ompK36 was performed following manufacturer instructions (QiaExpressionist - Qiagen) using E. coli BL21(DE3) bacterial cells and Ni-NTA resin (QIAGEN).
All experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at the Department of Veterinary Science of Università degli Studi di Milano (2011-Nr 3) and follow the European regulations for animal experimentation (Directive 2010/63/EU). All the methods were carried out in accordance with the approved guidelines.
Animals and diet
Forty- 6-week-old male ApoE−/− and C57BL/6 mice (Charles River Laboratories) were single-housed in Specific Pathogen-Free (SPF) conditions with free access to food and water. A red tunnel (VWR International) was placed in every cage for environmental enrichment. After weaning, mice were fed with Normal Diet (ND) containing 3% (w/w) fat (4RF21 certificate - Mucedola). At 6 weeks of age they were switched to a Western Diet (WD) consisting of 21% (w/w) fat and 0,2% cholesterol (TD88137 – Harlan) for an additional 24 weeks.
At 6 weeks of age, mice were randomly assigned to different groups and immunized. (Fig. S1a) For the first immunization the antigen, i.e. ompK36, or adjuvant only (recombinant mouse IL-12, R&D systems, 1 μg IL-12 in 150 μl of sterile Dulbecco’s PBS), was administered intra-peritoneally (50 μg/antigen in adjuvant solution). In successive bursts (8, 10 and 12 weeks of age) it was injected subcutaneously (25 μg per antigen in 150 μl in adjuvant solution) (Fig. S1b). Mouse weight and the amount of consumed chow were monitored every week until sacrifice. At 30 weeks of age, mice were anesthetized by isofluorane inhalation and blood samples collected in sodium-EDTA, centrifuged (3000 rpm for 15 min) and stored in aliquots at −80 °C. Mice were sacrificed by excess of anesthesia, then infused with gadolinium-based contrast agent (Magnevist, Bayer) for MRI via left ventricle, followed by PBS and 4% paraformaldehyde in PBS. Specimens (heart with aorta, small intestine) were fixed overnight and cryoprotected in sucrose 10%, then embedded in OCT compound (Killik, BioOptica), frozen in isopentane/liquid nitrogen and stored at −80 °C. Liver, visceral adipose tissue, spleen, PBMC, large intestine, striated muscles and fecal material were harvested in RNAlater (Qiagen) and kept at −80 °C until usage.
Serum titers against bacterial antigens
ELISA assays were performed as previously described (27). Briefly, 1 μg per well of purified ompK36 was coated in PBS1x pH = 7,4 at 4 °C overnight in a microtiter plate (Corning). Plates were blocked with PBS/1% BSA for 1 h at 37 °C. Four washes were performed in an automated washer (Thermo Scientific) with PBS/0.05% Tween-20. Plates were then blocked with PBS/3% Milk/0.02% Sodium Azide for 2 h at 37 °C. Mouse sera diluted in PBS/1% BSA were incubated for 1 h at 37 °C. After washing 5 times with PBS/0,1% Tween-20, Goat anti-Mouse IgG (Fc specific) antibody (Sigma) (1:10000 in PBS/1% BSA) was incubated at 37 °C for 1 h. After washing with PBS/0,1% Tween-20, TMB solution (Pierce) was added in every well and incubated at 37 °C for 15 min. The colorimetric reaction was stopped with H2SO4 1 M solution and the Optical Density (O.D.) was measured at 450 nm by MultiSkan GO microplate reader (Thermo Scientific). Serum antibody titer was defined as the reciprocal of the dilution with mean O.D. two times higher than background. Only blank and secondary antibodies were included in every ELISA assay as controls.
Total cholesterol, triglycerides and LDL were evaluated at sacrifice by Ospedale San Raffaele Mouse Clinic (Milan - Italy). Circulating cytokines, chemokines and hormones were measured on stored samples by using Bio-Plex assays (Pro Mouse Diabetes Assay, Mouse Group I: 23-plex panel, Mouse Group II: 9-plex panel and Mouse Adiponectin assay) following manufacturer’s instruction using Bio-Plex 200 Suspension Array System (Biorad). Circulating apoE protein was measured by ELISA assays (mouse apoE Elisa Kit (USCN Life Science Inc.)).
Total RNA was extracted from homogenized tissues using RNeasy Mini kits (Qiagen). RNA was reverse-transcribed using RT2 First Strand Kit (Qiagen). One microgram of purified RNA was analyzed in every plate using Mouse Fatty Liver (PAMM-157Z, Qiagen) or Mouse Innate and Adaptive Immunity (PAMM-052Z, Qiagen) arrays. Reactions were performed using the RT2 SYBR Green/ROX Mastermix (Qiagen) and AbiPrism 7900HT Fast Real-Time PCR System (Life Technologies) following manufacturer’s instructions. Six different House-Keeping Genes (HKGs) were evaluated in every tissue: beta-actin (Actb), beta-2-microgobulin (B2m), glyceraldehyde 3-phosphate dehydrogenase (Gapdh), beta glucoronidase (Gusb), heat shock protein 90 kDa alpha class B member 1 (Hsp90ab1) and ribosomal protein L32 (Rpl32). Post-amplification melting curve analysis was performed to check for unspecific products and RT, PCR and genomic DNA controls were included to ensure the absence of inhibitors and genomic DNA contaminant. Threshold cycles (Ct-values) were normalized to at least 2 HKGs used within each sample to obtain sample-specific ΔCt values (=Ct gene of interest − Ct HKG). 2−ΔΔCt values were calculated to obtain fold expression levels, where ΔΔCt = (ΔCt treatment − ΔCt control). Analyses were performed with web-based Sabiosciences software available at http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php (v3.5) and differences were considered significant if P < 0.05.
Bacterial DNA from 50 mg of fecal material and the surrounding colonic mucosa was extracted using PowerFecal DNA Isolation Kit (MoBio), following manufacturer’s instruction, but lysis time was increased to 15 min. Purified DNA was quantified and 200 ng per reaction was used to amplify 16S V3–5 regions using barcoded sample-specific primers, AccuPrime Taq Polimerase (Invitrogen) and the following cycling protocol: 95 °C for 5 min, 40 cycles of (95 °C for 30″, 55 °C for 45″ and 72 °C for 1 min) and stored at 4 °C until usage. Amplicons were loaded on 1% agarose gel and purified with QiaQuick Gel Extraction kit (Qiagen). Extracted amplicons were purified with AMPure XP beads (Beckman Coulter) and used for emulsion-PCR and ultra-deep pyrosequencing following 454 GS Junior manufacturer’s instruction (Roche). After quality filtering, resulting sequences (>250bp) were analyzed with QIIME software (1.6.0). The GM was analyzed in fecal samples from 7 mice/group with at least 15000 high-quality sequences/sample. Good’s coverage index was >0,99 for all the samples. Correlation between plasma proteins levels and single OTU were evaluated in QIIME with Bonferroni’s correction.
Magnetic Resonance Imaging (MRI) of atherosclerotic plaques
OCT-embedded heart and aorta were melted and washed with PBS1X and then included in 20% porcine gelatin (Sigma) in PBS 1% Pen./Strep. to insure stability in ex vivo MRI procedures. MRI was performed by a 7 Tesla small-bore scanner (Bruker BioSpec 70/30) equipped with a circular polarized body volume coil. MRI protocol included a 3-D RARE T2-weighted sequence (TR = 2800 ms; TE = 40 ms; NEX = 6) with isotropic voxel size. The acquired datasets were transferred on 32-bit OsiriX software (v7.7.1) for post-processing using curved multiplanar reformation (MPR) method. Both straightened/stretched long-axis views and short-axis trans-axial views of the aorta were obtained. Different frames of continuous short-axis images with a mean thickness of 100 μm were exported for each atherosclerotic plaque detected on long-axis curved MPR views of the aorta. Using these new datasets of short-axis views of the aorta, the areas of the aortic lumen and the atherosclerotic plaque were measured and summed up to obtain a volume on ImageJ 64-bit (v1.47). The aortic arch, in which plaques were evaluated more deeply, were defined from the beginning of the aortic root to the subclavian artery. The plaque volumes and plaque distribution along aortic arches were calculated from the obtained data.
Histology and morphometry
Serial cryosections from the aortic root (10-micron thick) were obtained from 5 mice/group and were destined to either Hematoxylin/Eosin or Oil Red O or Sirius Red staining, following standard methods. Either lipids, collagen, or calcifications were measured in the aortic root cryosections. Images of aortic root sections were taken using the Eclipse55i microscope equipped with a DS-L1 camera and Lucia G software (all from Nikon, Tokyo, Japan). At least 6 sections/mice distanced 300 μm apart were obtained and analyzed by using ImageJ software. Either the total plaque areas, or the areas occupied by lipid, collagen and calcifications were selected as Region Of Interest (ROI). After conversion to binary, a suitable threshold was selected and the areas measured. For all the considered parameters, the percentage of areas/section was calculated and all the values/mouse/group were averaged. Reagents were purchased from BioOptica and Sigma.
Immunofluorescence and morphometry
Cryosections (10 microns thick) of the aortic root and arch and of the small intestine were tested by immunofluorescence for the presence of macrophages and T-Lymphocytes. Sections of the aorta and/or small intestine were rinsed in Dulbecco’s PBS, permeabilized with 0,5% Triton-X100 in PBS (1 h room temperature, RT). Aspecific binding on aortic tissue was blocked by 1% BSA in PBS (1 h, RT), in the small intestine by 10% Donkey serum (Sigma-Aldrich)60. The sections were incubated with opportune primary antibodies. Goat anti-ArgI (sc-18351, Santa Cruz Biotechnology, CA, diluted 1:50, 4 °C overnight), Rat anti-Mouse CD68 (clone FA-11, BioLegend, diluted 1:100, 2 h RT), Goat anti-Mouse CD206 (sc-34577, Santa Cruz Biotechology, diluted 1:50 in 5% Donkey serum, 0,3% Triton-X100 in PBS, 4 °C overnight), Rabbit anti-Mouse CD3 (ab5690, Abcam, diluted 1:50, 2 h RT), were used, revealed either by Donkey anti-Goat-IgG-AlexaFluor488 (A-11055) anti-Rabbit-IgG-AlexaFluor488 (A-21206) and Donkey anti-Rat-IgG-AlexaFluor594 (A-21209, Molecular Probes, Life Technologies Inc.) all diluted 1:500 and applied for 45 min RT. Nuclei were counterstained with 4,6-diaminidino-2-phenylindole (Sigma-Aldrich, 0.2 nmol/L, diluted 1:250, 10 min. RT). Finally, slides were mounted with FluorSave (Merck) and analyzed under an Eclipse55i fluorescence microscope equipped with a DS-L1 camera and Lucia G software (Nikon, Tokyo, Japan). Cell counts were performed using ImageJ software. In the aortic root at least 400 cells/section in at least two sections/mouse in 5 mice/group were counted. Total cell density was calculated, the proportion of CD68+ cells was obtained as a the ratio CD68+ cells/total cell number; the percentage of ArgI+ cells was calculated as percentage of the ratio ArgI+ cells/CD68+ cell number. In sections from the small intestine, a minimum of 100 cells/section was counted in at least 5 sections/mouse in 5 mice/group. The CD3+ cell density was calculated as the ratio of CD3+ cells/total area occupied by intestinal villi (determined similarly to plaque area by ImageJ software). CD68+ cells were determined by the percentage of CD68+ cells/total cell number inside villi (epithelial cells excluded). The percentage of CD68+/CD206+ cells was also calculated.
All data sets were tested for normality with the D’Agostino-Pearson omnibus K2 normality test with a significance level set to p = 0.05 before the appropriate parametric or nonparametric statistical comparison test was carried out using Graphpad Prism (v5.0 – GraphPad Software) and JMP (v11 - SAS) software. Data were plotted as the mean ± Standard Error of the Mean (S.E.M.). Differences between two groups were assessed using a two-tailed, unpaired Student t test with Welch’s correction, if required. Considering the number of mice or samples analyzed and the observed variability, the statistical power of the analyses was between 0,8 and 1,0 for all parameters. Significant differences are indicated in the figures by *p < 0.05, **p < 0.01 and ***p < 0.001.
How to cite this article: Saita, D. et al. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci. Rep. 6, 29353; doi: 10.1038/srep29353 (2016).
Mardis, E. R. & Next-generation D. N. A. sequencing methods. Annual review of genomics and human genetics 9, 387–402 (2008).
Koren, O. et al. Human oral, gut and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 108, Suppl 1, 4592–4598 (2011).
Koizumi, Y., Kurita-Ochiai, T., Oguchi, S. & Yamamoto, M. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect Immun 76, 2958–2965 (2008).
Laurat, E. et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104, 197–202 (2001).
Ali, K., Middleton, M., Pure, E. & Rader, D. J. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 97, 922–927 (2005).
Grainger, D. J., Reckless, J. & McKilligin, E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173, 6366–6375 (2004).
Greenow, K., Pearce, N. J. & Ramji, D. P. The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl) 83, 329–342 (2005).
Serino, M. et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61, 543–553 (2012).
Zhu, Y., Kodvawala, A. & Hui, D. Y. Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms. Biochem J 428, 47–54 (2010).
Rensen, P. C. et al. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest 99, 2438–2445 (1997).
Nankar, S. A. & Pande, A. H. Physicochemical properties of bacterial pro-inflammatory lipids influence their interaction with apolipoprotein-derived peptides. Biochim Biophys Acta 1831, 853–862 (2013).
Werb, Z. et al. The cell and molecular biology of apolipoprotein E synthesis by macrophages. Ciba Found Symp 118, 155–171 (1986).
Werb, Z., Takemura, R., Stenberg, P. E. & Bainton, D. F. Directed exocytosis of secretory granules containing apolipoprotein E to the adherent surface and basal vacuoles of macrophages spreading on immobile immune complexes. The American journal of pathology 134, 661–670 (1989).
Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).
Stenman, L. K., Holma, R. & Korpela, R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World journal of gastroenterology: WJG 18, 923–929 (2012).
Moreira, A. P., Texeira, T. F., Ferreira, A. B., Peluzio Mdo, C. & Alfenas Rde, C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. The British journal of nutrition 108, 801–809 (2012).
Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481 (2008).
Cho, K. Y. et al. The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 22, 910–918 (2013).
Ramachandran, G. Gram-positive and gram-negative bacterial toxins in sepsis: A brief review. Virulence 5, 213–218 (2014).
Gerber, J. S. & Mosser, D. M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol 166, 6861–6868 (2001).
Raffai, R. L. Apolipoprotein E regulation of myeloid cell plasticity in atherosclerosis. Curr Opin Lipidol 23, 471–478 (2012).
Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677–686 (2004).
Bonney, R. J., Naruns, P., Davies, P. & Humes, J. L. Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins 18, 605–616 (1979).
Ambarus, C. A. et al. Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10. PLoS One 7, e35994 (2012).
Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278–286 (2012).
Wlodarska, M. et al. NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion. Cell 156, 1045–1059 (2014).
Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745–757 (2011).
Tilg, H. & Moschen, A. R. Microbiota and diabetes: an evolving relationship. Gut 63, 1513–1521 (2014).
McLean, M. H., Dieguez, D., Jr., Miller, L. M. & Young, H. A. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 64, 332–341 (2015).
Jones, G. W. et al. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis. Atherosclerosis 238, 321–328 (2015).
Cristell, N. et al. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. J Am Coll Cardiol 58, 2654–2661 (2011).
Binder, C. J. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 30, Suppl 1, S56–60 (2010).
Palinski, W., Miller, E. & Witztum, J. L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92, 821–825 (1995).
Ameli, S. et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16, 1074–1079 (1996).
Grasset, E. K. et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc Natl Acad Sci USA 112, E2030–2038 (2015).
Kyaw, T. et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 109, 830–840 (2011).
Mantani, P. T. et al. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice. PLoS One 10, e0117255 (2015).
Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat Immunol 12, 204–212 (2011).
Lichtman, A. H., Binder, C. J., Tsimikas, S. & Witztum, J. L. Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 123, 27–36 (2013).
Ait-Oufella, H. et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207, 1579–1587 (2010).
Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204 (2007).
Aung, P. P., Jr. et al. Calcium Intake among Myanmar Residing in Bago, Kayin and Yangon Areas. Malaysian journal of nutrition 16, 91–100 (2010).
Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nat Immunol 12, 5–9 (2011).
Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231–241 (2012).
Ordovas, J. M. & Mooser, V. Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 17, 157–161 (2006).
Stepankova, R. et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 17, 796–804 (2010).
Dalager-Pedersen, M., Sogaard, M., Schonheyder, H. C., Nielsen, H. & Wernich Thomsen, R. Risk for Myocardial Infarction and Stroke after Community-Acquired Bacteremia: A 20-Year Population-Based Cohort Study. Circulation (2014).
Kim, K. A., Gu, W., Lee, I. A., Joh, E. H. & Kim, D. H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7, e47713 (2012).
Amar, J. et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO molecular medicine 3, 559–572 (2011).
Hamze, Z. et al. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma. Endocrine-related cancer 20, 833–848 (2013).
Ellis, T. N. & Kuehn, M. J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74, 81–94 (2010).
Jager, J. et al. Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. Infect Immun 82, 275–285 (2014).
Nakao, R. et al. Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response. PLoS One 6, e26163 (2011).
Burioni, R. et al. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J Immunol 183, 2537–2544 (2009).
Canducci, F. et al. Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients. PLoS One 7, e42283 (2012).
Caesar, R., Fak, F. & Backhed, F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268, 320–328 (2010).
Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011).
Sheikh, A. & Strachan, D. P. The hygiene theory: fact or fiction? Curr Opin Otolaryngol Head Neck Surg 12, 232–236 (2004).
Hrncir, T., Stepankova, R., Kozakova, H., Hudcovic, T. & Tlaskalova-Hogenova, H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol 9, 65 (2008).
Choi, K. M. et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology 138, 2399–2409, 2409 e2391 (2010).
This study was partially funded by the Italian Ministry of University and Research and by the Italian Ministry of Health (grant GR-2011-02347170). Authors are grateful to Massimo Dagrada, Joel Felipe and prof. Paola Dall’Ara from University of Milan for useful advice and assistance in mouse facility. Authors are grateful to Reza Milano for English editing.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Saita, D., Ferrarese, R., Foglieni, C. et al. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep 6, 29353 (2016). https://doi.org/10.1038/srep29353
American Journal of Physiology-Heart and Circulatory Physiology (2019)
Molecular Neurobiology (2019)
Current Atherosclerosis Reports (2017)
Antibiotic use associated with VTE and its implications: a new trigger for thromboprophylaxis and for reclassification of some unprovoked to provoked VTE's?
British Journal of Haematology (2017)